Publications by authors named "Manoj Kanhangad"
Article Synopsis
- A study aimed to explore how genetic diagnoses in epilepsy patients impact their clinical management and health outcomes, focusing on data from patients tested for genetic variants between 2016 and 2020.
- The research included 418 patients, with a median age of 4 years, and found that nearly half (49.8%) experienced changes in clinical management due to genetic results, often within three months.
- Common changes included starting new medications, referrals to specialists, and monitoring for other health issues related to the genetic findings.*
Objective: To describe in detail the clinical profile of Charcot-Marie-Tooth disease subtype 3 (CMTX3) to aid appropriate genetic testing and rehabilitative therapy.
Methods: We reviewed the clinical and neurophysiologic profile and CMT Pediatric Scale (CMTPedS) assessments of 11 children with CMTX3.
Results: Compared with the more common forms of CMT, CMT1A and CMTX, CMTX3 was characterized by early onset with early and progressive hand weakness.
Aim: We present a new and unique association of opsoclonus-myoclonus-ataxia syndrome with neuroblastoma and type 1 diabetes mellitus.
Patient Description: This 17-month-old child presented with opsoclonus-myoclonus-ataxia syndrome. Investigations revealed a thoracic neuroblastoma.